Home of Containment Solutions

Lugaia News – Insights into Containment, Innovation & Industry Trends

Stay up to date with our latest projects, product innovations and trade fair appearances

Welcome to the Lugaia Newsroom – your source for the latest updates on our containment solutions, single-use technologies, and company developments. Here you’ll find news about new products, successful projects, partnerships, and industry events. Discover how Lugaia supports safe, efficient processes across the pharmaceutical, biotech, and chemical sectors.

High Containment Systems: From SafePort to SafePort Evo

Evolving high-containment powder transfer for greater efficiency and flexibility

Handling highly potent active pharmaceutical ingredients (HPAPIs) demands reliable containment, particularly during powder transfer. Modern transfer systems must combine maximum safety with efficient workflows, intuitive handling and flexibility.

Lugaia’s SafePort systems meet these requirements: While the established SafePort offers a robust solution for larger product volumes, the new SafePort Evo features a more compact design, simplified handling and unlimited docking cycles.

Ventilation Technology for Flexible Isolators: Why Controlled Airflow Is Critical

Flexible isolator systems offer a high degree of flexibility for a wide variety of containment processes. A crucial component of the overall system is the appropriate ventilation technology. It ensures controlled airflow and defined pressure conditions within the isolator, thereby creating the essential conditions for safe and controlled processes.

But what exactly does a ventilation unit do? When are negative or positive pressures required? And which functions are relevant for more demanding containment applications?

Lugaia at POWTECH 2025 – Experience Product Premieres and Expert Insights Live (Kopie)

Meet us from September 23–25, 2025 in Nuremberg, Hall 12, Booth #12-352

POWTECH is the leading trade fair for mechanical process engineering, analytics, and the handling of powders and bulk materials. This year, Lugaia will once again be on site – with special highlights. In addition to our comprehensive product portfolio, we are excited to present two brand-new innovations that set new benchmarks in single-use containment.

Flexible vs. rigid isolators

The right containment strategy for modern production requirements

HPAPIs, ADCs and increasingly stringent OEB 5 and OEB 6 requirements are fundamentally changing the demands placed on containment solutions. Manufacturers face the challenge of reliably protecting operators, complying with regulatory requirements and maintaining cost-efficient production. One of the key questions is: Should companies choose flexible or rigid isolators?

The answer depends on several factors, including production volume, cleaning requirements and available investment budgets. In this article, we explore the key differences between flexible and rigid isolators and explain which solution may be the better choice for different applications.

Visit Lugaia at INTERPHEX 2026 – Booth #1639

From April 21–23, 2026, Lugaia will exhibit at INTERPHEX at the Javits Center in New York City — one of the leading global trade shows for pharmaceutical manufacturing, biotechnology production, and aseptic processing technologies. At Booth #1639, Lugaia will present its latest containment solutions and single-use technologies for safe and efficient powder handling in highly regulated production environments. Our systems are designed to meet the strict requirements of high-potency API handling, OEB containment, and GMP-compliant pharmaceutical processes.

Lugaia Aussenaufnahmen Gebäude Raron StandortLugaia Aussenaufnahmen Gebäude Raron Standort

Lugaia Aussenaufnahmen Gebäude Raron Standort

Press Release

From Valais to the world: Lugaia celebrates 20 years of innovation and international growth

In 2026, Lugaia AG looks back on 20 years of successful business operations. What began two decades ago in Upper Valais has evolved into an internationally active company providing flexible containment solutions for the pharmaceutical, biotech and chemical industries.

Safely Scaling ADC Manufacturing with OEB-6 and Double Containment

How Lugaia's High-Containment Solutions enable safe, efficient and compliant ADC Production

The biopharmaceutical industry is advancing rapidly into highly potent therapies - especially antibody-drug conjugates (ADCs) - which bring unique challenges for manufacturing, containment and operator safety. At Lugaia, we understand that meeting these challenges requires top-class containment strategies, such as OEB-6 classification and double‐containment systems, combined with flexible single-use and customized solutions. This article explains why OEB-6 and double-containment matter in ADC manufacturing, what to look for and how Lugaia’s solutions support safe, efficient operations.

Lugaia Trade Fairs & Events 2026

International Trade Fairs and Conferences for Pharma, Biotech and High-Containment

The year 2026 once again offers numerous international trade fair and event highlights for the pharmaceutical and process industries. Lugaia will be there again this year – meet us live on site and discover our latest solutions for containment, powder handling and safe pharmaceutical processes.

Season's Greetings from the Containment Wonderland

Creating safe spaces – even for Christmas magic

We are on company holidays from 19 December to 5 January 2026.

SafeSeal DuoPro – The new 2-in-1 solution for OEB-5 containment

Innovative crimp and cut tool for safe pharmaceutical processes

With the SafeSeal DuoPro, Lugaia expands its portfolio of containment solutions with an innovative 2-in-1 tool. Specially developed for use in isolators and cleanrooms, it combines crimping and cutting in a single device. Delivering GMP-compliant seals and meeting the strictest OEB-5 containment requirements (<1 µg/m³), the SafeSeal DuoPro ensures maximum safety when handling highly potent active pharmaceutical ingredients (HPAPIs) – protecting operators, products, and the environment.